ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Herpes Simplex Virus (HSV) Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27U9373
Home | Market Reports | Health| Reproductive Health
Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2028
BUY CHAPTERS

Global Herpes Simplex Virus (HSV) Vaccines Market Research Report 2025

Code: QYRE-Auto-27U9373
Report
September 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
GlaxoSmithKline PLC
Genocea Biosciences
Vical Inc

Herpes Simplex Virus (HSV) Vaccines Market Size

The global market for Herpes Simplex Virus (HSV) Vaccines was valued at US$ 947 million in the year 2024 and is projected to reach a revised size of US$ 1446 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Herpes Simplex Virus (HSV) Vaccines Market

Herpes Simplex Virus (HSV) Vaccines Market

Herpes simplex virus (HSV) is known for causing herpes infection. This is majorly found on genitals or mouth and can also be seen on various body parts. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Herpes Simplex Virus (HSV) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Simplex Virus (HSV) Vaccines.
The Herpes Simplex Virus (HSV) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Herpes Simplex Virus (HSV) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Simplex Virus (HSV) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Herpes Simplex Virus (HSV) Vaccines Market Report

Report Metric Details
Report Name Herpes Simplex Virus (HSV) Vaccines Market
Accounted market size in year US$ 947 million
Forecasted market size in 2031 US$ 1446 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • GEN-003
  • VCL-HB01
  • HSV529
  • Others
Segment by Application
  • HSV-1 (Oral Herpes)
  • HSV-2 (Genital Herpes)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, GlaxoSmithKline, Genocea Biosciences, Vical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Herpes Simplex Virus (HSV) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Herpes Simplex Virus (HSV) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Herpes Simplex Virus (HSV) Vaccines Market growing?

Ans: The Herpes Simplex Virus (HSV) Vaccines Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Herpes Simplex Virus (HSV) Vaccines Market size in 2031?

Ans: The Herpes Simplex Virus (HSV) Vaccines Market size in 2031 will be US$ 1446 million.

Who are the main players in the Herpes Simplex Virus (HSV) Vaccines Market report?

Ans: The main players in the Herpes Simplex Virus (HSV) Vaccines Market are Sanofi, GlaxoSmithKline, Genocea Biosciences, Vical

What are the Application segmentation covered in the Herpes Simplex Virus (HSV) Vaccines Market report?

Ans: The Applications covered in the Herpes Simplex Virus (HSV) Vaccines Market report are HSV-1 (Oral Herpes), HSV-2 (Genital Herpes)

What are the Type segmentation covered in the Herpes Simplex Virus (HSV) Vaccines Market report?

Ans: The Types covered in the Herpes Simplex Virus (HSV) Vaccines Market report are GEN-003, VCL-HB01, HSV529, Others

Recommended Reports

Virus Vaccine Markets

Flu and Multivalent Vaccines

Vaccine Delivery & Storage

1 Herpes Simplex Virus (HSV) Vaccines Market Overview
1.1 Product Definition
1.2 Herpes Simplex Virus (HSV) Vaccines by Type
1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 GEN-003
1.2.3 VCL-HB01
1.2.4 HSV529
1.2.5 Others
1.3 Herpes Simplex Virus (HSV) Vaccines by Application
1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Value by Application (2024 VS 2031)
1.3.2 HSV-1 (Oral Herpes)
1.3.3 HSV-2 (Genital Herpes)
1.4 Global Herpes Simplex Virus (HSV) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue 2020-2031
1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales 2020-2031
1.4.3 Global Herpes Simplex Virus (HSV) Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Herpes Simplex Virus (HSV) Vaccines Market Competition by Manufacturers
2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Herpes Simplex Virus (HSV) Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Herpes Simplex Virus (HSV) Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Date of Enter into This Industry
2.8 Global Herpes Simplex Virus (HSV) Vaccines Market Competitive Situation and Trends
2.8.1 Global Herpes Simplex Virus (HSV) Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Herpes Simplex Virus (HSV) Vaccines Players Market Share by Revenue
2.8.3 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Herpes Simplex Virus (HSV) Vaccines Market Scenario by Region
3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2020-2031
3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2020-2025
3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region: 2026-2031
3.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2020-2031
3.3.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2020-2025
3.3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2026-2031
3.4 North America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.4.1 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2031)
3.4.3 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.5.1 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2031)
3.5.3 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2031)
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2020-2025)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2026-2031)
4.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2020-2031)
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2020-2025)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2026-2031)
4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2031)
5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2020-2025)
5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2026-2031)
5.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2020-2031)
5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2020-2025)
5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2026-2031)
5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Genocea Biosciences
6.3.1 Genocea Biosciences Company Information
6.3.2 Genocea Biosciences Description and Business Overview
6.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.3.5 Genocea Biosciences Recent Developments/Updates
6.4 Vical
6.4.1 Vical Company Information
6.4.2 Vical Description and Business Overview
6.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Product Portfolio
6.4.5 Vical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Herpes Simplex Virus (HSV) Vaccines Industry Chain Analysis
7.2 Herpes Simplex Virus (HSV) Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Herpes Simplex Virus (HSV) Vaccines Production Mode & Process Analysis
7.4 Herpes Simplex Virus (HSV) Vaccines Sales and Marketing
7.4.1 Herpes Simplex Virus (HSV) Vaccines Sales Channels
7.4.2 Herpes Simplex Virus (HSV) Vaccines Distributors
7.5 Herpes Simplex Virus (HSV) Vaccines Customer Analysis
8 Herpes Simplex Virus (HSV) Vaccines Market Dynamics
8.1 Herpes Simplex Virus (HSV) Vaccines Industry Trends
8.2 Herpes Simplex Virus (HSV) Vaccines Market Drivers
8.3 Herpes Simplex Virus (HSV) Vaccines Market Challenges
8.4 Herpes Simplex Virus (HSV) Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
GlaxoSmithKline PLC
Genocea Biosciences
Vical Inc
List of Tables
 Table 1. Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Herpes Simplex Virus (HSV) Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Herpes Simplex Virus (HSV) Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Herpes Simplex Virus (HSV) Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Herpes Simplex Virus (HSV) Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Herpes Simplex Virus (HSV) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Herpes Simplex Virus (HSV) Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Herpes Simplex Virus (HSV) Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Herpes Simplex Virus (HSV) Vaccines Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Genocea Biosciences Company Information
 Table 81. Genocea Biosciences Description and Business Overview
 Table 82. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product
 Table 84. Genocea Biosciences Recent Developments/Updates
 Table 85. Vical Company Information
 Table 86. Vical Description and Business Overview
 Table 87. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Vical Herpes Simplex Virus (HSV) Vaccines Product
 Table 89. Vical Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Herpes Simplex Virus (HSV) Vaccines Distributors List
 Table 93. Herpes Simplex Virus (HSV) Vaccines Customers List
 Table 94. Herpes Simplex Virus (HSV) Vaccines Market Trends
 Table 95. Herpes Simplex Virus (HSV) Vaccines Market Drivers
 Table 96. Herpes Simplex Virus (HSV) Vaccines Market Challenges
 Table 97. Herpes Simplex Virus (HSV) Vaccines Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Herpes Simplex Virus (HSV) Vaccines
 Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Type: 2024 & 2031
 Figure 4. GEN-003 Product Picture
 Figure 5. VCL-HB01 Product Picture
 Figure 6. HSV529 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Herpes Simplex Virus (HSV) Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application: 2024 & 2031
 Figure 10. HSV-1 (Oral Herpes)
 Figure 11. HSV-2 (Genital Herpes)
 Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Sales (2020-2031) & (K Units)
 Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Average Price (USD/Unit) & (2020-2031)
 Figure 16. Herpes Simplex Virus (HSV) Vaccines Report Years Considered
 Figure 17. Herpes Simplex Virus (HSV) Vaccines Sales Share by Manufacturers in 2024
 Figure 18. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Herpes Simplex Virus (HSV) Vaccines Players: Market Share by Revenue in Herpes Simplex Virus (HSV) Vaccines in 2024
 Figure 20. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2020-2031)
 Figure 23. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2020-2031)
 Figure 27. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2020-2031)
 Figure 35. China Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Herpes Simplex Virus (HSV) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Herpes Simplex Virus (HSV) Vaccines by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Herpes Simplex Virus (HSV) Vaccines by Type (2020-2031)
 Figure 57. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Herpes Simplex Virus (HSV) Vaccines by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Herpes Simplex Virus (HSV) Vaccines by Application (2020-2031)
 Figure 60. Global Herpes Simplex Virus (HSV) Vaccines Price (USD/Unit) by Application (2020-2031)
 Figure 61. Herpes Simplex Virus (HSV) Vaccines Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Herpes Simplex Virus Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herpes Simplex Keratitis Drug Market Insights Forecast to 2030
Global Genital Herpes Treatment Drugs Market Insights Forecast to 2030
Global Drugs for Herpes Labialis Oral Herpes Market Insights Forecast to 2030
Herpes Simplex Keratitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genital Herpes Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Varicella Live Vaccine Market Insights Forecast to 2030
Global Avian Pox Vaccine Market Research Report 2024
Global Herpes Simplex Virus Testing Kits Market Research Report 2024
Global HSV Antibody Market Research Report 2024
Global Viral Vector Vaccine for Humans Market Research Report 2024
Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herpes Zoster Ophthalmicus Drug Market Insights Forecast to 2030
Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herpes Simplex Virus Testing Market Research Report 2024
Global Live Herpes Zoster Vaccine Market Research Report 2024
Global Monkeypox Virus Vaccine Market Research Report 2024
Global Sexually Transmitted Diseases STD Testing Market Insights Forecast to 2030
Global Herpes Infection Treatment Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions